Vitamin D and cardiovascular health by Bonnici, Maria
it is well-known that vitamin D supplementation improves bone strength and deficiency leads to rickets in children and osteoporosis in adults.1 Through observational studies it was noted that vitamin 
D deficiency is an independent risk factor for cardiovascular 
disease.2,3 In 2008, Giovannucci et al., reported that in The Health 
Professional Follow-Up Study which was conducted on 50,000 men, 
those men who were deficient in vitamin D were twice more likely 
to suffer from a myocardial infarction than those with adequate 
levels.4 Additionally, in a cohort of patients, Ford et al., identified a 
statistically significantly association between low vitamin D levels and 
obesity, glucose intolerance, metabolic syndrome and hypertension, 
which all increase the risk of cardiovascular disease.5 This manuscript 
will review how vitamin D deficiency may predispose to coronary 
problems and how adequate vitamin D stores may improve 
cardiovascular health.  
Vitamin D comes in two forms, ergocalciferol (vitamin D2) and 
cholecalciferol (vitamin D3). Vitamin D2 is found in mushrooms 
and specific plants e.g. alfalfa, whilst vitamin D3 is primarily found 
in oily fish. Both can also be found in fortified foods or supplements.  
Additionally, vitamin D3 can be synthesised cutaneously in humans 
from irradiation of 7-dehydrocholesterol by ultraviolet B radiation.
The liver converts vitamin D to 25-hydroxyvitamin D [25(OH)
D], or calcidol, which is the major circulating metabolite and 
reflects vitamin D intake and endogenous production. Serum 
measures of 25(OH)D reflect the true vitamin D status. 25(OH)
D is then converted, primarily in the kidneys, to the active form 
1,25-dihydroxyvitamin D [1,25(OH)2D] or calcitriol. This hormone 
maintains bone health and cardiovascular health. One must note that 
this active form does not correlate with the overall vitamin D status of 
the person and therefore its assays are not clinically useful.1 Calcitriol, 
together with its receptor - present throughout the body including the 
vascular smooth muscle, endothelium and myocardium - in turn bind 
to retinoic acid x-receptor and serve as a nuclear transcription factor. 
This alters gene function including protein synthesis. Indirectly or 
directly vitamin D has the power to regulate over 200 genes, including 
those responsible for renin production in the kidney, growth and 
proliferation of both cardiomyocytes and vascular smooth muscle 
cells, insulin production in the pancreas and the release of cytokines 
by lymphocytes.1
Experimental studies in vitamin D-deficient animals have shown 
that they have an increased risk of hypertension, atherosclerosis and 
left ventricular hypertrophy.6 In humans it was found that vitamin 
D inhibits renin gene expression and therefore it lowers down blood 
pressure through the rennin-angiotensin pathway.7 Detrimental 
cardiovascular effects were found with hyperparathyroidism which 
could be the result of chronic vitamin D deficiency.  Vitamin D 
deficiency leads to decrease in intestinal calcium absorption which in 
turn triggers parathyroid hormone release and eventually secondary 
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hyperparathyroidism. An increase in parathyroid hormone levels leads 
to mobilization of calcium from bone, increased renal tubular calcium 
reabsorption and increased renal production of 1,25(OH)2D. In 2003, 
Vestergaard and Mosekilde reported that patients who underwent 
surgical parathyroidectomy due to hyperparathyroidism had 
approximately 40% lower relative risks of myocardial infarction and 
stroke.8 Moreover, an observational study on elderly patients found 
that those elderly individuals with elevated parathyroid hormone 
had a doubling-mortality when compared with those elderly with a 
normal parathyroid hormone.9 The physiology behind this is that an 
increased parathyroid hormone level is associated with an increase 
in both blood pressure and myocardial contractility. This eventually 
leads to myocardial hypertrophy, apoptosis, and fibrosis of both the 
left ventricle and the vascular medial smooth muscle.10 Furthermore, 
Andersson et al. found that in patients with moderate or severe 
chronic kidney disease, vitamin D deficiency and/or an increase in 
parathyroid hormone predisposes to calcification of the heart valves 
and myocardium.11
Vitamin D has anti-inflammatory properties;12 in fact, low vitamin 
D levels increase systemic inflammation, evidenced by elevated 
serum C-reactive protein and interleukin-10.10 Elevated circulating 
concentrations of pro-inflammatory cytokines could contribute to the 
pathogenesis of congestive heart failure. On the other hand, a recent 
double-blind, randomized, placebo-controlled trial has suggested 
that vitamin D supplementation reduces the inflammatory milieu in 
congestive heart failure patients.13
Who needs testing for vitamin deficiency or vitamin D 
supplementation? 
Testing and supplementation is not recommended for everyone. These 
may be advised for people who are in long term care, bed-bound, 
or there is a medical condition which is indicative of vitamin D 
deficiency such as hypocalcaemia and hypophosphataemia. Patients 
with a history of bone fracture or osteopenia/osteoporosis should also 
be investigated for possible supplementation. On the market there 
are many different vitamin D preparations with the most commonly 
available being vitamin D2 and vitamin D3. It is recommended to take 
vitamin D3 when possible because it is the naturally occurring form 
of vitamin D. Obviously supplementation depends on the severity of 
the vitamin D deficiency. If the vitamin D levels are <20ng/ml, the 
treatment usually includes 50,000 IU of vitamin D2 or D3 once or 
more per week for 6-8 weeks, and then 800-1000 IU of vitamin D daily. 
If the vitamin D levels are 20-30ng/ml, the recommended treatment is 
800-1000 IU daily for a 3 month period. Once normal levels of vitamin 
D are achieved it is recommended to continue with 800 international 
units daily. In people who have medical conditions which predispose 
to low vitamin D levels, the recommended dose of vitamin D will be 
determined on an individual basis.1 
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